Temporal Dependence of the Effect of Radiation on Erlotinib-Induced Skin Rash-Reference-Cited by-同舟云学术

Temporal Dependence of the Effect of Radiation on Erlotinib-Induced Skin Rash

Published:2007-05-20 Issue:15 Volume:25 Page:2140-2140
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Lacouture Mario E.¹,Hwang Catherine¹,Marymont MaryAnne H.¹,Patel Jyoti¹

Affiliation:

1. Skin and Eye Reactions to Inhibitors of EGFR and Kinase S, Department of Dermatology, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center; and the Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.09.4045

Reference7 articles.

1. Erlotinib Induced Skin Rash Spares Skin in Previous Radiotherapy Field

2. Cutaneous Adverse Effects With HER1/EGFR-Targeted Agents: Is There a Silver Lining?

3. Mechanisms of cutaneous toxicities to EGFR inhibitors

4. Sitton E: Early and late radiation-induced skin alterations: Part I: Mechanisms of skin changes. Oncol Nurs Forum 19: 801,1992-807,

5. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the radioprotective effects of the liposomal forms of five natural radioprotectants in alleviating the adverse effects of ionising irradiation on human lymphocytes and skin cells in radiotherapy;Journal of Microencapsulation;2023-10-16

2. Dermatologic Adverse Events;The MASCC Textbook of Cancer Supportive Care and Survivorship;2018

3. Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients;European Journal of Oncology Nursing;2016-02

4. Mechanisms underlying skin disorders induced by EGFR inhibitors;Molecular & Cellular Oncology;2015-06

5. Target Therapies in Pancreatic Carcinoma;Current Medicinal Chemistry;2014-02